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Until recently, interest  in  the  embryonic expression of  transplantation antigens 
has focused primarily upon the question of why pregnancies within genetically het- 
erogeneous  mammalian populations  are  predominantly  successful,  despite the  fre- 
quent dissimilarity between mother  and fetus for genes determining important histo- 
compatibility antigens (1, 2). 
A  new  impetus for  studying H-antigen ontogeny stems  from  the  evidence that 
these cell substances may play an important role in the processes of cellular differ- 
entiation, particularly those events which  determine immunological competence or 
potentiate  carcinogenesis.  The  association  of  histocompatibility-2  (H-2)" antigen 
phenotype in mice with the capacity to resist oncogenic viruses (3,  4) or to respond 
to  antigen stimulation (5)  indicates a  biological significance other than that which 
relates to transplantation of tissues. 
Early suggestions that histocompatibility antigens were not expressed in embryos 
or that they occurred in a nonimmunogenic form have been convincingly refuted by 
a  number  of investigations. These studies have shown that in mice, tubal eggs  and 
blastocysts can be prevented from developing when transferred to the kidney capsules 
of specifically sensitized recipients (6, 7), that 9-day old embryonic tissues are rejected 
when grafted to preimmunized host  (8),  and  that pregnancy can,  in  fact, result in 
maternal sensitization to histocompatibility antigens (9). 
Most of the  experiments cited were performed before the  general availability of 
congenic resistant (CR)  strains of mice  (10)  which make it possible to study single 
specific histocompatibility antigen systems. Therefore, conclusions could not be made 
as to which of the many mouse histocompatibility systems were operative, or whether 
antigens of the highly immunogenic H-2 system were present. 
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Schlesinger (11)  reported absorptions of H-2 agglutinins by tissues from  10.5-day 
old  fetuses,  the youngest  studied.  Attempts  to  detect H-2  antigens  at  earlier  em- 
bryonic  stages  have had variable results which may  be  due,  in  some  instances,  to 
complications  of  non-H-2  incompatibilities  existing  between  the  strains used  for 
grafting or for production of antibody (12-17). 
Heyner et al., taking advantage of antiserum  produced by immunizations between 
CR  strains,  studied  the  effects  of  /-/-2  allo-antibody  on  the  development  of  tubal 
mouse  eggs  to  blastocysts  in vitro  (18).  Although some  antisera known  to  contain 
both H-2 and non-H-2  antibody destroyed the eggs,  those containing 11-2 antibody 
alone failed to impede blastocyst formation, even in the presence of guinea pig serum 
as  a  source  of  complement.  The  results  suggested  a  deficiency  or  absence  of  It-2 
sites at these early stages. 
To  test  this  proposal  more  directly,  immunofluorescence  has  been  used  to 
look for the presence of H-2 and non-H-2  specificities on fertilized mouse eggs 
at the two-cell stage.  The results of the study have been presented in prelimi- 
nary form (19)  and are reported in detail here. 
Materials and Methods 
Mice.--Lymphocytes  or eggs from mice of the following inbred strains were used in the 
immunofluorescence tests:  B10.D2/new  Sn  (B10.D2),  A/J,  C3H/He,  C57BL/10Sn  (B10), 
and  DBA/2J.  All mice were  obtained from the Jackson Laboratory, Bar Harbor,  Maine. 
They were maintained after arrival for periods of 1-3 wk before use. 
Target Cdls.--Fertilized  eggs at the two-cell stage were collected from superovulated mice 
8-10 wk old.  Female mice received  10 IU of pregnant mare serum  (Gestyl, Organon, Inc., 
West Orange, N.J.) followed 48 hr later by 10 IU of human chorionic gonadotropin (Pregnyl, 
Organon, Inc.). Females were placed with males immediately after the second injection and 
were checked for the presence of vaginal copulation plugs next morning. Approximately 24 
hr later the oviducts were removed and the two-cell embryos flushed from the tubes, accord- 
ing to the method of Brinster (20).  The eggs were washed with Brinster's medium for ovum 
culture (BMOC2) and the zona pellucida, which may act as a protective barrier around the 
egg, was removed by gentle digestion with 0.25% pronase. Removal of the zonae was moni- 
tored continuously to assure minimum exposure of the blastomeres to the enzyme. When the 
zonae were so thin as to be only just discernible, the eggs were transferred to culture medium, 
and this trauma caused the final loss of the zona. Blastocysts were obtained by flushing the 
oviducts and uterus 31~ days after mating and removing the zona pellucida as described above, 
or alternatively, four-cell eggs were cultured in vitro to the blastocyst stage, and those blasto- 
cysts which were normal in appearance were utilized. Some of these had hatched from the 
zona and so did not require the pronase treatment; these embryos acted as a control for the 
reactivity of blastocysts whose zonae were removed enzymatically. 
Unfertilized eggs were obtained by fushing the oviduct the morning after the administration 
of Pregnyl. Cumulus cells were removed by a  brief exposure  to  hyaluronidase,  after which 
the zona was removed as described above. 
Lymphocytes were obtained by teasing the axilliary, brachial, and mesenteric lymph nodes. 
After  washing  twice  in  phosphate-buffered  saline  (PBS)  supplemented  with  5%  normal 
mouse serum,  the cells were  suspended  at concentrations of  10  ~ cells/ml for the immuno- 
fluorescence tests. 
Serological Methods.--The  H-2-containing  antisera  used  were  obtained  after  multiple 
injections of cells from lymphoid tissue or cultured cell lines as summarized in Table I. Ag- 1284  H-2  AND  NON  H-2  ANTIBODY 
glutinin titers were determined by the human serum-dextran test  (21), while cytotoxic ac- 
tivity was determined by a conventional dye-exclusion test, by ~'Cr-release  (22), or both. To 
increase  the probability of detecting low  concentrations of  surface H-2  antigen,  antisera 
obtained from several combinations of donor-recipient immunizations were pooled to broaden 
the range of cross-reactive antibodies. 
Two antisera known to contain only non-H-2 antibody were available.  One of these, M-218, 
was prepared by immunizations of the B10.LP  strain with tissues of B10  mice.  These CR 
strains differ at the H-3 locus (10) and the resulting antibody is presumably directed toward 
II-3 antigens of B10. The second serum, M-220, was obtained by injecting tissues and tissue 
extracts from the H-2-compatible B10.D2  strain into DBA/2  mice.  M-220  had a  hemag- 
glutinin titer of  1/640,  but lacked cytolytic activity for lymphocytes. Tests on segregating 
populations indicated that antibody was directed to antigens of a single  locus.  The antibody 
in tests on 15 inbred strains, reacted with or was absorbed by only those strains possessing 
the H-6.A  antigen described by Amos et al.  (23). The H-6 and H-3 antigens are determined 
by genes in the same linkage group (24). 
Serum absorptions were performed by mixing well-washed lymphoid cells  (spleen,  lymph 
node, thymus) with the appropriately diluted antibody and incubating the mixture for 30 
min at 37°C before recovering the absorbed serum by centrifugation. 
Immunofluorescence Technique.--The  procedure used was similar  to  that  originally de- 
scribed by M011er for living cell suspensions (25). Two-cell  embryos or cultured blastocysts 
were incubated with 0.03  ml of undiluted allo-antisera or control (nonimmune or syngeneic 
immune) sera for 25 min at 37°C in an atmosphere of 5% CO2 in air. The number of two-cell 
embryos in each sample varied between 20 and 80, while there were usually under 10 blasto- 
cysts/test. After incubation the cells were washed three times with BMOC2 in order to re- 
move unbound selum. The cells were then incubated with 0.05 ml of a suitably diluted fluo- 
rescein-conjugated anti-mouse globulin  (Microbiological  Associates,  Bethesda, Md.),  after 
which a  minimum of three washings with medium was used to remove excess conjugate. A 
few blastomeres became separated during the washing and  recentrifuging process, but  the 
majority remained intact. For microscopic observation, a  drop of 50% medium in glycerol 
was added to the sediment, and a drop of the suspended cells was placed on a slide under a 
cover slip. To avoid distortion of the blastomeres, small slivers of glass were used to support 
the weight of the cover slips.  Because the number of mouse embryos surviving the test pro- 
cedure was limited, all visible embryos were counted on every slide.  All cells showing any 
bright green membrane fluorescence  were counted, and the distribution over the surface of 
the cell was noted. One unavoidable difficulty encountered in the study was the propensity 
for early embryonic cells to incorporate macromolecules,  as has been described by Glass (26). 
This resulted in a faint, nonspecific internal staining of all specimens. However, no difficulty 
was  encountered in  distinguishing serologically  specific  membrane fluorescence  from  this 
incorporation or from the diffuse, intense fuorescence indicative of cell death. 
RESULTS 
Immunofluorescence of Two-Cell Eggs.--The  tests gave three kinds of results: 
no visible surface membrane fluorescence, staining which appeared as intense 
fluorescent patches evenly distributed over the surface of the blastomeres (Fig. 
1),  or infrequently, staining which occurred as a  few sparsely distributed Small 
FIG.  1.  Two-cell mouse embryos exhibiting specific immunofluorescence after treatment 
with allo-antisera. Supported cover slips permit maintenance of spherical shape of large cells 
and by focusing one can see typical ring type of staining (a)  or patchy stain upon surface 
membrane (b, c). Disintegrating polar body visible in  (b). Figures are of B10.D2  cells from 
three different tests after treatment with H-6 antiserum, M-220.  >( 400. Figure 1. 
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spots. A nonspecific internal fluorescence, resulting from the tendency of mouse 
eggs to incorporate macromolecules, occurred in all samples regardless of treat- 
ment  but  there  was no difficulty distinguishing  this  from positive membrane 
fluorescence.  The use  of fluorescein-conjugated anti-mouse  globulin  alone did 
not result  in  surface membrane  staining  of the  eggs,  nor did  treatment  with 
normal mouse serum before exposure to the conjugated fluorescein. 
Tests for H-2 Specificities.--Table I  indicates  the  results  of tests  with  sera 
known to contain H-2 antibody. The H-2 cytolytic titers  of all  antisera  were 
reasonably high and lymphocytes treated with the sera exhibited considerable 
staining. The antisera were of two types: those (rows 1, 2) which should contain 
TABLE I 
H-2Antlbody  Tests 
Antibody 
H-2 
H-2 plus 
non-H-2 
Immunization 
A.SW anti-A 
B10 anti-B 10.D2 
C3H anti-B 10 
C57BL/6 anti-L5178Y 
Pod 1 (anti-H-2~+)§ 
Pool 2 (anti-H-2k+)§ 
Cyto- 
lyric 
titer 
320  0(2)* 
640 
320 
2560 
2560 
640 
2-cell embryos from strain 
C3H  B10  B10.D2 
(H-2  k )  (H-2  b )  (H-2  d ) 
0(1) 
o~(1) 
+  (2) 
o(2) 
+  (2) 
+  (2) 
DBA/2 
(g-2  a ) 
0,(1) 
+  (2) 
* Numbers in parenthesis indicate test replicates. 0 =  No reactivity,  +  =  Reactivity. 
:~ Occasional embryo with minimal stain. 
§ Mixtures of equal volumes of antisera containing H-2 cytotoxic antibody from following 
immunizations: Pool 1: C3H anti-DBA/2; C57BL anti-DBA/2; C3H anti-A; C57BL anti-A; 
Pool 2: BS/VS anti-C3H; DBA/2 anti-C3H;  C57BL/6 anti-C3H;  A anti-C3H. 
H-2  antibody  only,  because  they resulted  from immunizations  in  which  the 
donor  and  recipient  were  H-2  CR  strains  (10),  and  those  (rows 3-6),  which 
could, and in some instances were known to, contain various non-H-2 antibodies 
in addition to H-2. 
Five tests (10-25 specimens/test)  were performed with the two CR antisera, 
using  embryos from four inbred  strains.  The tests  were classified  as negative 
because the majority of embryos exhibited no staining.  However, in each test 
with  the  CR  serum  a  few specimens were observed exhibiting  small,  isolated 
stained  areas.  This kind  of reactivity was not  observed in  control specimens 
and,  therefore,  may be of significance. 
In contrast, all those antisera coming from immunizations in which non-H-2 
antibody might  develop in  addition  to  H-2  specificities  gave  evidence  of re- 
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CR H-2 antisera that had failed to react. This observation, plus the failure of 
anti-L-5178Y sera to react with eggs of the B10.D2  strain which has the same 
1t-2 ~ antigen as DBA/2, suggested that the reactions observed were non-H-2. 
Support  for  this  possibility  came  from  absorption  analysis  of  the  high- 
titered anti-H-2  d serum, pool No. 1, as shown in Table II. For the absorptions, 
tissues of the CR lines B10 (H-2  b) and  B10.D2  (1t-22)  were used.  The strains 
differ for the 11-2 chromosome region only; consequently, absorption with B10 
tissues should remove all antibodies cross-reactive with B10.D2  tissues except 
those detecting  the H-2  ~ antigen of this strain.  The B10  tissues  removed  re- 
activity for B10.D2 eggs, despite the remaining presence of H-2  d antibody,  as 
indicated by the reactivity of B10.D2 lymphocytes. Absorptions with B10.D2 
lymphoid tissue removed all activity for both eggs and lymphocytes. 
Tests for Individual  Non-11-2 Specificities.--Embryos  from three of the four 
TABLE II 
Tests for  Specificity  of Reactivity  with  Antiserum  (Pool 1)*  Containing  H-2 and  Non-H-2 
Antibody 
Absorption with lymphoid cells of 
Cells tested 
2-cell embryo 
B10.D2 
Lymphocytes 
C57BL/10  B 10,D2 
--  +(2)t  +  + 
C57BL/10  0 (2)  0  + 
B 10.D2  0 (1)  0  0 
* Mixture of antisera produced in five different strains (see Materials and Methods). See 
footnote Table I. 
Number of tests. 
strains tested reacted with the putative H-6 antibody, whereas eggs from the 
serum  donor  strain,  DBA/2,  were  consistently negative in  two  tests  (Table 
liD.  The serological specificity of the reactions was confirmed by  absorption 
analyses (Table IV). 
M-218,  the  antiserum produced by immunization of CR lines differing for 
1t-3 antigens, had a low agglutinating titer and no obvious cytolytic antibody, 
but it produced marked positive reactions with B10 and B10.D2  eggs (Table 
III). 
Unfertilized Eggs.--Three  tests were done on unfertilized eggs of the B10.D2 
strain,  using CR H-2  antisera  elicited in B10  donors.  A  total of 30  eggs was 
examined, all of which were completely negative. 
Immunofluorescence  of Blastocysts.--The  failure to obtain H-2  reactivity at 
the two-ceU stage prompted a study of more mature embryos. The blastocyst, 
a  multicellular form occurring in vivo at about 72  hr after fertilization,  may 
also be obtained by culturing early embryos in vitro. From 4 to 10 blastocysts 1288  H-2  AND  NON  H-2  ANTIBODY 
in  each  of  eight  experiments  were  tested  for  the  presence  of  11-2  antigens. 
Interpretation  of the results was hampered by nonspecific fluorescent staining, 
resulting both from uptake of fluorescein and from what appeared to be entrap- 
ment  within  the blastocoele  cavity.  Despite  this,  it was clear  that  in normal 
specimens imrnunofluorescence of most cellular surface membrane was absent 
and that the majority of outer exposed cells were not obviously reactive with H-2 
antibody (Fig. 2). 
An interesting feature of the tests was the occurrence in all antibody-treated 
TABLE  III 
Non-It-2 Antibody  Tests 
Non-H-2  2-cen embryos from 
Antiserum  Antibody  agglutinin  BI0  B10.D2  DBA/,2 
titer  (H-2  b)  (H-~)  (H-2  ~) 
DBA/2 anti-B10.D2  H-6*  640  +  +  0 
B10.LP anti-C57BL/10  H-3*  40  +  +  0 
C57BL/6 anti-L-5178Y  H-2 +  unknown  None  0  0  + 
non-H-2  detected :~ 
* See text for immunization procedure used. 
:~ Tests on DBA/2 RBC after absorption with B10.D2 tissues. 
TABLE IV 
Serological Specificity  of H-6 Antibody Tests  (Antiserum:  DBA /2  (H-2  d)  anti-BlO.D2  [H-gd]) 
Absorption with 
lymphocytes of 
2-cell embryos from 
A  B10  BI0.D2  DBA/2 
--  +(i)*  +(2)  +(4) 
DBA/2  +  (1)  +  (2) 
B10.D2  0 (1) 
B10  0 (1)  0 (1) 
0(2) 
* Number of tests. 
specimens of a few localized areas of intense staining  (Fig. 2).  This was found 
after treatment with both the pooled anti-H-2  ~ and CR tl-2  antiserum,  for  a 
total  of eight apparently  normal blastocysts.  It was not observed in  tests  of 
three blastocysts treated with B10 normal serum before exposure to the fluores- 
cein conjugate. 
DISCUSSION 
More than 40 tests with fertilized mouse embryos of the two-cell stage have 
shown  (a)  that  serologically-specific tests  for  histocompatibility  allo-antigen 
on the surface of mammalian  two-cell embryos are feasible,  (b)  that 11-2 anti- JOY  PALM:, SUSAN HEYNER~ AND R.  L.  BRINSTER  1289 
gens,  if  they are  expressed  at  this  stage,  are beyond detection  with  the  test 
system as employed, and (c)  that  the immunofluorescent reactivity of eggs to 
specific  allo-antiserum  seems  not  to  be  correlated  with  antibody  activity  as 
detected  by other  serological  tests.  Sera  with  weak  agglutinating  titers  and 
FIG. 2.  Cultured  B10.D2 blastocyst exhibiting localized, intensely stained  area after  im- 
munofluorescent treatment.  Most surface areas unstained.  X 400. 
with  no  cytolytic activity for lymphocytes exhibited  marked  reactivity  with 
eggs, while potent H-2 antibody failed to react. 
The  ease with  which  evidence was obtained  of non-H-2 expression  at  this 
early stage was surprising.  Reactivity to both 1t-3  and 11-6  antisera appeared 
as patchy staining  over  the  entire  surface  of the  cells.  The 11-3  antigens  are 
considered to be in the category of weak transplantation  antigens in adults (10) 
and as such may have fewer sites exposed on the surface of cells. 1t-6,  a  blood 1290  H-2  AND NON H-2  ANTIBODY 
group antigen, is not known to be involved in transplantation reactions but does 
occur in variable amounts on some adult tissues (23). The apparent abundance 
of reactive sites on the blastomeres is therefore of interest. 
The two non-H-2 antigens detected in these studies are determined by genes 
located in close proximity within the fifth chromosome linkage group (10,  24). 
It may be relevant that this region has been implicated in two kinds of antigen- 
associated  phenomena  of  probable  embryonic  initiation:  a  maternal-fetal 
interaction  that causes a  prenatal selective disadvantage to H-3 homozygous 
individuals (27)  and the development of immunological competence to respond, 
by producing antibody,  to a  genetically-defined red cell antigen of mice (28). 
All evidence available indicates that, when present on cells, H-2 antigens are 
more easily detected  serologically than  are the various non-H-2 specificities. 
Moreover, the antisera detecting the latter in these studies exhibited consider- 
ably less antibody by several conventional serological tests than did the H-2- 
containing antisera. In light of these facts, the failure to detect H-2 sites seems 
unlikely to be due to insensitivity of the test system. 
The possibility that the pronase used  to disrupt  the zona pellucida caused 
enzyme degradation of H-2 sites is more difficult to exclude as an explanation 
for the  results.  Nevertheless,  several lines  of evidence do argue  against  this. 
These include the very limited exposure of the blastomeres during zona disrup- 
tion, the cleanly negative surfaces of most cells treated with H-2 antibody, and 
the observation that similar concentrations  of enzyme were ineffective in di- 
minishing the reactivity of lymphocytes to H-2 antibody. Furthermore, in our 
earlier  studies  (19),  culturing  of  eight-cell  embryos with  //-2  antibody  plus 
complement for 2  days did  not  impede development to blastocysts.  Even  if 
pronase treatment in these experiments had been sufficiently damaging to have 
cleaved//-2 sites, as has been reported to occur after papain treatment of some 
tumor cells (29), the subsequent regeneration of these sites, by analogy, should 
have occurred sufficiently early for the antibody to have an effect. 
Perhaps the most compelling argument against pronase digestion as a reason 
for the absence of reactivity to H-2 antibody was the failure to detect surface 
//-2 on cells of the hatched blastocysts; these had not been subjected to pronase 
treatment. The results support the conclusions from the earlier studies (19)  that 
expression of//-2 antigens is either nonexistent or very deficient on the surface 
of the developing zygote during  early stages of embryogenesis. Similarly, un- 
fertilized eggs also appear to be lacking in//-2 sites that are detectable either 
by the  immunofluorescence  tests  described here or in  the  cytotoxic tests re- 
ported by Baranska et al. (30). 
The results are in contrast to reports that//-2  determinants are  sufficiently 
concentrated  on  sperm  to  allow  detection  with  cytotoxic  antibody  (31-33). 
Speculation concerning the meaning of this apparent difference in H-2 expres- 
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absence of unequivocal evidence of the haploid or diploid nature of the 1-1-2 
phenotype of sperm. It is conceivable that the difference may reflect dissimilar 
opportunities for adsorption of 11-2 substances from body fluids during matura- 
tion (33). 
Whatever its physiological basis,  the lack of readily detectable H-2 sites on 
the early zygote is convenient. In the absence of 11-2 complications, for example, 
hyperimmune anti-tumor sera may be readily analyzed for antibodies detecting 
other cell  surface antigens such as those that may be common to embryonic 
and malignant cells (30, 34-36), or those representing defined non-11-2 systems 
whose role in differentiation may be of greater biological significance than is 
their effectiveness in invoking transplantation  immunity. 
SUMMARY 
Mouse embryos at the two-cell and blastocyst stages, as well as unfertilized 
eggs,  have been studied by indirect immunofluorescence for the expression of 
H-2  and  non-H-2  histocompatibility  antigens  on  surface  membranes.  Sero- 
logically-specific reactivity to non-H-2 antibody (1-1-3 and 11-6)  was observed 
as diffuse, patchy staining over the entire surface of the blastomeres at the two- 
cell stage. In contrast, no reactivity of two-cell or unfertilized egg embryos of 
four inbred strains was observed when antisera  containing only multispecific 
11-2 cytolytic antibody were used. Antisera containing 11-2 along with non-/-/-2 
antibody of unknown specificity showed varying degrees of reactivity, which 
could be shown by absorption studies to be due to the non-H-2 content of the 
serum. The results suggest that the initial expression of histocompatibility genes 
varies and support the hypothesis that the appearance of these cell components 
may relate to specific  stages of differentiation. 
The authors wish to acknowledge the generous advice of Dr. Stefan Zeplewski for pho- 
tography of early test results and the able technical assistance of Mrs. Carol Cavalcanto. 
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